ERIS logo

Eris Lifesciences Limited Stock Price

NSEI:ERIS Community·₹217.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

ERIS Share Price Performance

₹1,600.80
230.85 (16.85%)
13.9% undervalued intrinsic discount
₹1,860.10
Fair Value
₹1,600.80
230.85 (16.85%)
13.9% undervalued intrinsic discount
₹1,860.10
Fair Value
Price ₹1,600.80
AnalystConsensusTarget ₹1,860.10

ERIS Community Narratives

AnalystConsensusTarget·
Fair Value ₹1.86k 13.9% undervalued intrinsic discount

India's Shift To Branded Generics Will Expand Chronic Therapy Markets

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent ERIS News & Updates

Is Eris Lifesciences Limited (NSE:ERIS) Worth ₹1.8k Based On Its Intrinsic Value?

Aug 28
Is Eris Lifesciences Limited (NSE:ERIS) Worth ₹1.8k Based On Its Intrinsic Value?

Here's Why Eris Lifesciences (NSE:ERIS) Can Manage Its Debt Responsibly

Jul 26
Here's Why Eris Lifesciences (NSE:ERIS) Can Manage Its Debt Responsibly

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 26%

Jun 17
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 26%

Eris Lifesciences' (NSE:ERIS) Conservative Accounting Might Explain Soft Earnings

May 26
Eris Lifesciences' (NSE:ERIS) Conservative Accounting Might Explain Soft Earnings

Eris Lifesciences Limited Key Details

₹29.4b

Revenue

₹7.4b

Cost of Revenue

₹22.0b

Gross Profit

₹18.1b

Other Expenses

₹3.9b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
28.38
Gross Margin
74.88%
Net Profit Margin
13.17%
Debt/Equity Ratio
75.7%

Eris Lifesciences Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

High growth potential with acceptable track record.

2 Risks
2 Rewards

About ERIS

Founded
2007
Employees
3354
CEO
Amit Bakshi
WebsiteView website
www.eris.co.in

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.9%
  • 3 Months: -1.2%
  • 1 Year: -3.8%
  • Year to Date: 1.2%
The market is up 1.9% over the last week, with the Financials sector leading the way, up 2.3%. Longer term the market is actually down 3.8% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›